Allergy Therapeutics (AGY)

London
26.30
-0.55(-2.05%)
  • Volume:
    171,121
  • Bid/Ask:
    26.00/27.70
  • Day's Range:
    26.10 - 27.61

AGY Overview

Prev. Close
26.85
Day's Range
26.1-27.61
Revenue
81.76M
Open
26.25
52 wk Range
12.4-27.7
EPS
0.01
Volume
171,121
Market Cap
168.79M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
236,410
P/E Ratio
29.90
Beta
1.44
1-Year Change
84.56%
Shares Outstanding
641,772,718
Next Earnings Date
-
What is your sentiment on Allergy Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Allergy Therapeutics News

Allergy Therapeutics Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong BuyStrong Buy
Technical IndicatorsStrong SellStrong SellSellStrong BuyStrong Buy
SummaryStrong SellStrong SellSellStrong BuyStrong Buy

Allergy Therapeutics Company Profile

Allergy Therapeutics Company Profile

Employees
0

Allergy Therapeutics plc engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex, Pollinex Quattro, Oralvac, Acarovac Plus, Acarovac MPL, Venomil, Synbiotics, Penicillin Diagnostics, and Peanut. The company also develops allergy vaccines for grass, tree, and house dust mite, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.

Read More
  • Am buying tomorrow .( .there might be some good news coming )
    1
    • Am buying tomorrow .( ..near might be some good news coming )
      1
      • it a good time to sell
        1
        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.